SELLAS Life Sciences CEO Angelos Stergiou says his company is already on the cusp of a finalized leukemia vaccine, but another game-changer – personalized cancer vaccines – could be on the horizon, thanks to artificial intelligence.
“I think it’s going to be a revolutionary decade in medicine and in clinical research,” he said Thursday on “Fox & Friends.”
“Where AI comes into play is where it’s going to allow us to do things expeditiously, and it’s going to be more personalized. In other…
Article Source
https://www.foxnews.com/media/biotech-ceo-revolutionary-move-curing-cancer-horizon-ai
